Literature DB >> 1744686

Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

M S Mahaley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1744686     DOI： 10.1007/bf02390173

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  360 in total

1.  A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma.

Authors:  M J Garrett; H J Hughes; L S Freedman
Journal:  Clin Oncol       Date:  1978-03

2.  The interaction of drug and radiation effects on normal tissues.

Authors:  T L Phillips; K K Fu
Journal:  Int J Radiat Oncol Biol Phys       Date:  1978 Jan-Feb       Impact factor: 7.038

3.  Treatment of grade III and IV astrocytomas with BCNU alone and in combination with VM-26 following surgery and radiation therapy.

Authors:  D L Sweet; F J Hendler; K Hanlon; J Hekmatpanah; M L Griem; E E Duda; B Mulligan; R L Wollman
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

4.  Preliminary clinical trial of immunotherapy for malignant glioma.

Authors:  M Ingram; C H Shelden; S Jacques; R G Skillen; W G Bradley; G B Techy; D B Freshwater; R M Abts; R W Rand
Journal:  J Biol Response Mod       Date:  1987-10

5.  Radiotherapy and L-triiodothyronine in the treatment of high-grade astrocytoma.

Authors:  P Morales; A Bosch; R Lopez; C Nery; F Borras; M Rosa
Journal:  J Surg Oncol       Date:  1988-10       Impact factor: 3.454

6.  Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

Authors:  U Tirelli; M D'Incalci; R Canetta; S Tumolo; G Franchin; A Veronesi; E Galligioni; M G Trovò; C Rossi; E Grigoletto
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

7.  Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme.

Authors:  T J Kinsella; J Collins; J Rowland; R Klecker; D Wright; D Katz; S M Steinberg; E Glastein
Journal:  J Clin Oncol       Date:  1988-05       Impact factor: 44.544

8.  A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors.

Authors:  M C Chamberlain; M D Prados; P Silver; V A Levin
Journal:  J Neurooncol       Date:  1988-12       Impact factor: 4.130

9.  Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report.

Authors:  H S Greenberg; W D Ensminger; J F Seeger; G W Kindt; F Chandler; K Doan; S R Dakhil
Journal:  Cancer Treat Rep       Date:  1981 Sep-Oct

10.  Single agent therapy of interferon for brain tumours: correlation between natural killer activity and clinical course.

Authors:  S Otsuka; H Handa; J Yamashita; K Suda; J Takeuchi
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216
View more
  20 in total

1.  Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.

Authors:  F Hochberg; M Prados; C Russell; D Weissman; R Evans; P Cook; G Burton; P D Eisenberg; R Valenzuela; L Verkh
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

2.  Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol).

Authors:  William J Bodell; Alexander P Bodell; Donald D Giannini
Journal:  Neuro Oncol       Date:  2006-10-03       Impact factor: 12.300

3.  Penetration of idarubicin into malignant brain tumor tissue.

Authors:  W Boogerd; I S Tjahja; M M van de Sandt; J H Beijnen
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

4.  Test for chemotherapeutic sensitivity of cerebral gliomas: use of the colorimetric MTT assay.

Authors:  J C Tonn; G Nikkhah; J L Darling; W Schachenmayr
Journal:  J Neurooncol       Date:  1993-05       Impact factor: 4.130

5.  Tumorigenic, invasive, karyotypic, and immunocytochemical characteristics of clonal cell lines derived from a spontaneous canine anaplastic astrocytoma.

Authors:  M E Berens; G Bjotvedt; D C Levesque; M D Rief; J R Shapiro; S W Coons
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

6.  Effect of n3-methyladenine and an isosteric stable analogue on DNA polymerization.

Authors:  Samuel Settles; Ruo-Wen Wang; Gilberto Fronza; Barry Gold
Journal:  J Nucleic Acids       Date:  2010-09-19

7.  Brain tumor protocols in North America.

Authors:  M Bernstein; J Rutka
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

8.  Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015.

Authors:  William J Bodell; Donald D Giannini; Saira Singh; Dennis Pietronigro; Victor A Levin
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

9.  Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report.

Authors:  D D Bigner; M Brown; R E Coleman; A H Friedman; H S Friedman; R E McLendon; S H Bigner; X G Zhao; C J Wikstrand; C N Pegram
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients.

Authors:  A Boiardi; A Silvani; P A Ruffini; L Rivoltini; G Parmiani; G Broggi; A Salmaggi
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.